News headlines about INC Research Holdings (NASDAQ:INCR) have trended somewhat positive recently, according to Accern Sentiment. Accern rates the sentiment of press coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. INC Research Holdings earned a daily sentiment score of 0.06 on Accern’s scale. Accern also assigned media stories about the company an impact score of 0 out of 100, indicating that recent press coverage is extremely unlikely to have an effect on the company’s share price in the near future.
Here are some of the media headlines that may have impacted Accern Sentiment Analysis’s analysis:
- UPDATE: William Blair Downgrades INC Research Holdings (INCR) to Market Perform Ahead Of Merger Agreement (streetinsider.com)
- Pamplona Capital Management nears deal to buy Parexel-source (finance.yahoo.com)
- INC Research Holdings, Inc. (INCR) Rating Lowered to Market Perform at William Blair (americanbankingnews.com)
- Jefferies Group LLC Reaffirms “Buy” Rating for INC Research Holdings, Inc. (INCR) (americanbankingnews.com)
- Q4 2017 Earnings Estimate for INC Research Holdings, Inc. (INCR) Issued By KeyCorp (americanbankingnews.com)
INCR has been the subject of a number of research reports. TheStreet raised shares of INC Research Holdings from a “c” rating to a “b-” rating in a report on Monday, April 17th. Jefferies Group LLC reissued a “buy” rating and set a $51.00 price target on shares of INC Research Holdings in a report on Friday, April 21st. Goldman Sachs Group, Inc. (The) cut shares of INC Research Holdings from a “conviction-buy” rating to a “buy” rating and set a $51.00 price target for the company. in a report on Wednesday, March 1st. SunTrust Banks, Inc. raised shares of INC Research Holdings from a “hold” rating to a “buy” rating and increased their price target for the stock from $48.00 to $67.00 in a report on Wednesday, May 31st. Finally, Zacks Investment Research cut shares of INC Research Holdings from a “buy” rating to a “hold” rating in a report on Tuesday, March 7th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and six have assigned a buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus price target of $60.38.
Shares of INC Research Holdings (INCR) traded down 2.64% during mid-day trading on Tuesday, reaching $59.05. 723,905 shares of the company were exchanged. The company’s 50 day moving average price is $54.46 and its 200 day moving average price is $50.33. INC Research Holdings has a 12 month low of $36.70 and a 12 month high of $61.10. The firm has a market capitalization of $3.19 billion, a PE ratio of 28.09 and a beta of 1.47.
INC Research Holdings (NASDAQ:INCR) last released its earnings results on Wednesday, May 10th. The company reported $0.60 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.55 by $0.05. The firm had revenue of $252.10 million for the quarter, compared to analysts’ expectations of $250.76 million. INC Research Holdings had a return on equity of 43.17% and a net margin of 7.37%. The business’s revenue for the quarter was up 1.2% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.58 earnings per share. Equities analysts anticipate that INC Research Holdings will post $2.69 earnings per share for the current year.
In related news, CEO Alistair Macdonald sold 9,467 shares of the company’s stock in a transaction that occurred on Monday, May 1st. The stock was sold at an average price of $45.00, for a total value of $426,015.00. Following the sale, the chief executive officer now directly owns 83,935 shares in the company, valued at $3,777,075. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CAO Christopher L. Gaenzle sold 4,733 shares of the company’s stock in a transaction that occurred on Monday, April 3rd. The shares were sold at an average price of $45.70, for a total value of $216,298.10. Following the completion of the sale, the chief accounting officer now owns 53,050 shares in the company, valued at $2,424,385. The disclosure for this sale can be found here. Insiders own 0.24% of the company’s stock.
ILLEGAL ACTIVITY WARNING: This article was first published by Sports Perspectives and is owned by of Sports Perspectives. If you are reading this article on another website, it was illegally stolen and reposted in violation of international trademark & copyright laws. The legal version of this article can be accessed at https://sportsperspectives.com/2017/06/20/inc-research-holdings-incr-given-news-sentiment-rating-of-0-06-updated-updated-updated-updated.html.
INC Research Holdings Company Profile
INC Research Holdings, Inc is a global contract research organization (CRO). The Company focuses on Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. The Company operates through two segments: Clinical Development Services and Phase I Services.
Receive News & Ratings for INC Research Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for INC Research Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.